Advisor Group Holdings, Inc. Athira Pharma, Inc. Transaction History
Advisor Group Holdings, Inc.
- $39.8 Billion
- Q4 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Athira Pharma, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 81,300 shares of ATHA stock, worth $25,203. This represents 0.0% of its overall portfolio holdings.
Number of Shares
81,300
Previous 82,350
1.28%
Holding current value
$25,203
Previous $37,000
27.03%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding ATHA
# of Institutions
62Shares Held
18.8MCall Options Held
17.2KPut Options Held
800-
Perceptive Advisors LLC New York, NY5.4MShares$1.67 Million0.11% of portfolio
-
Bml Capital Management, LLC Zionsville, IN2.78MShares$860,5241.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.56MShares$482,5610.0% of portfolio
-
Simplify Asset Management Inc. New York, NY1.49MShares$462,7650.05% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.49MShares$462,7650.87% of portfolio
About Athira Pharma, Inc.
- Ticker ATHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,817,700
- Market Cap $11.7M
- Description
- Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...